Wenjun Chen
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
-
- Tryptophan and brain disorders
Papers in
-
- Protein Degradation and Inhibitors 1
-
- Medicinal Plant Pharmacodynamics Research 2
- Pharmacological Effects of Natural Compounds 2
- Co-authors
- Xueyuan Heng (1 shared paper)Guangxi Zhai (1 shared paper)Feng Yuan (1 shared paper)Yingjie Zhai (1 shared paper)Dezhong Sun (1 shared paper)Weidong Liu (1 shared paper)Miao Guo (2 shared papers)Shuli Wang (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (1 paper)Journal of drug targeting (1 paper)International Journal of Medical Sciences (1 paper)Pain Medicine (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wenjun Chen
12 papers receiving 633 citations
Wenjun Chen's Hit Papers
Peers
Comparison fields: 5 of 92
- Molecular Medicine 283
- Biological Psychiatry 29
- Pharmaceutical Science 57
- Biomaterials 72
- Complementary and alternative medicine 43
Countries citing papers authored by Wenjun Chen
This map shows the geographic impact of Wenjun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Chen more than expected).
Fields of papers citing papers by Wenjun Chen
This network shows the impact of papers produced by Wenjun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Chen. The network helps show where Wenjun Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenjun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Oral bioavailability of curcumin: problems and advancements Hit paper breakdown → | 2016 | 435 |
| 2 | 2023 | 62 | |
| 3 | 2017 | 29 | |
| 4 | 2016 | 28 | |
| 5 | 2017 | 27 | |
| 6 | 2018 | 16 | |
| 7 | 2021 | 14 | |
| 8 | Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma. | 2014 | 12 |
| 9 | 2017 | 10 | |
| 10 | 2017 | 9 | |
| 11 | Inhibition of janus kinase 2 by compound AG490 suppresses the proliferation of MDA-MB-231 cells via up-regulating SARI (suppressor of AP-1, regulated by IFN). | 2015 | 7 |
| 12 | 2024 | 2 | |
| 13 | 2024 | 0 | |
| 14 | 2025 | 0 |
About Wenjun Chen
Wenjun Chen is a scholar working on Molecular Biology, Pharmacology, Neurology, Complementary and alternative medicine and Physiology, having authored 14 papers that have together received 651 indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (2 papers), Medicinal Plant Pharmacodynamics Research (2 papers), Pain Mechanisms and Treatments (2 papers), Pharmacological Effects of Natural Compounds (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Protein Degradation and Inhibitors (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Alcohol Consumption and Health Effects (1 paper). The work is most often cited by research in Molecular Medicine (283 citations), Biological Psychiatry (29 citations), Pharmaceutical Science (57 citations), Biomaterials (72 citations) and Complementary and alternative medicine (43 citations). Wenjun Chen has collaborated with scholars based in China and United States. Frequent co-authors include Xueyuan Heng, Guangxi Zhai, Feng Yuan, Yingjie Zhai, Dezhong Sun, Weidong Liu, Miao Guo, Shuli Wang, Xinyi Qi and Li Huang. Their work appears in journals such as Toxicology and Applied Pharmacology, Journal of drug targeting, International Journal of Medical Sciences, Pain Medicine and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.